You are here

Medical Testing

Calls grow for US to rely on rapid tests to fight pandemic

WASHINGTON (AP) — When a Halloween party sparked a COVID-19 outbreak at North Carolina Agricultural and Technical State University, school officials conducted rapid screening on more than 1,000 students in a week, including many who didn’t have symptoms.

Although such asymptomatic screening isn’t approved by regulators and the 15-minute tests aren’t as sensitive as the genetic one that can take days to yield results, the testing director at the historically Black college credits the approach with quickly containing the infections and allowing the campus to remain open.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Low Reimbursements Are Causing Some Doctors to Stop Testing for Covid

Dr. Robin Larabee was thrilled to start offering coronavirus testing at her pediatrics practice in Denver last fall. Testing for children is often scarce, and her new machines could return results within minutes.

She quickly discovered an unexpected obstacle: a major health insurer that paid her less than the cost of the test itself. Each kit Dr. Larabee purchased for her machines cost about $41, but the insurer sent back half that amount each time she submitted a claim.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

‘Like Wartime’: Canadian Companies Unite to Start Mass Virus Testing

TORONTO — As frustration mounts in Canada at the leaden weight of lockdowns and the glacial pace of vaccinations, a consortium of some of the country’s largest companies has launched a rapid testing program with the aim of protecting their 350,000 employees and publishing a playbook for businesses across Canada on how to reopen safely.

The program is believed to be the first of its kind among the Group of 7 industrialized nations, and has already attracted the attention of the Biden administration.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS: How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead

Nearly a year into the coronavirus pandemic, as thousands of patients are dying every day in the United States and widespread vaccination is still months away, doctors have precious few drugs to fight the virus.

A handful of therapies — remdesivir, monoclonal antibodies and the steroid dexamethasone — have improved the care of Covid patients, putting doctors in a better position than they were when the virus surged last spring. But these drugs are not cure-alls and they’re not for everyone, and efforts to repurpose other drugs, or discover new ones, have not had much success.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Medical Testing
howdy folks
Page loaded in 0.658 seconds.